Investigational new drug for Alzheimer's scheduled for first study in humans

Investigational new drug for Alzheimer's scheduled for first study in humans:

Dementia Big
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

http://ift.tt/2iBMuQO